HRP20211099T1 - Postupak za pripreme gabapentina - Google Patents

Postupak za pripreme gabapentina Download PDF

Info

Publication number
HRP20211099T1
HRP20211099T1 HRP20211099TT HRP20211099T HRP20211099T1 HR P20211099 T1 HRP20211099 T1 HR P20211099T1 HR P20211099T T HRP20211099T T HR P20211099TT HR P20211099 T HRP20211099 T HR P20211099T HR P20211099 T1 HRP20211099 T1 HR P20211099T1
Authority
HR
Croatia
Prior art keywords
alkali
specified
formula
reaction
stated
Prior art date
Application number
HRP20211099TT
Other languages
English (en)
Inventor
Satchandra Kiran Divi
Mysore Aswatha Narayana Rao
Surendra Kalyan Nuthi
Original Assignee
Divi's Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Divi's Laboratories Limited filed Critical Divi's Laboratories Limited
Publication of HRP20211099T1 publication Critical patent/HRP20211099T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/10Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/88Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having the nitrogen atom of at least one of the carboxamide groups further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (8)

1. Postupak pripreme gabapentina koji obuhvaća korake: a) reakcije spiro[cikloheksan-1,9’-(3,7-diazabiciklo-[3.3.1]nonan)]-2’,4’,6’,8’-tetraona iz formule VI: [image] s lužinom kako bi se dobio 1,1-cikloheksan dioctena kiselina monoamid iz formule IV i [image] b) pretvaranja spoja IV dobivenog u koraku-a u gabapentin I putem Hofmannove reakcije koristeći alkalni hipohalit.
2. Postupak kao što je navedeno u zahtjevu 1, naznačen time što je lužina odabrana iz skupine koja se sastoji od natrijevog hidroksida, kalijevog hidroksida, litijevog hidroksida, natrijevog tert-butoksida i kalijevog tert-butoksida.
3. Postupak kao što je navedeno u zahtjevu 2, naznačen time što je lužina natrijev hidroksid.
4. Postupak kao što je navedeno u zahtjevu 3, naznačen time što je koncentracija lužine u rasponu od 5% do 50% ( w/V - mase po volumenu).
5. Postupak kao što je navedeno u zahtjevu 3, naznačen time što je koncentracija lužine u rasponu od 15% do 25% ( w/V - mase po volumenu).
6. Postupak kao što je navedeno u zahtjevu 1, naznačen time što se u koraku – a reakcija izvodi na temperaturi refluksa kroz vremenski period od 6 do 24 sata.
7. Postupak kao što je navedeno u zahtjevu 6, naznačen time što se u koraku – a reakcija izvodi kroz vremenski period od 15 do 20 sati.
8. Postupak kao što je navedeno u zahtjevu 1, naznačen time što se spoj formule VI korišten u koraku – a priprema reakcijom 2,4-diokso-3-aza-spiro[5.5]undekan-1,5-dikarbonitrila formule V [image] s 50% do 70% otopine sumporne kiseline na 90°C do 110°C.
HRP20211099TT 2018-08-01 2021-07-09 Postupak za pripreme gabapentina HRP20211099T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201841028887 2018-08-01
EP18199836.0A EP3604272B1 (en) 2018-08-01 2018-10-11 Process for the preparation of gabapentin

Publications (1)

Publication Number Publication Date
HRP20211099T1 true HRP20211099T1 (hr) 2021-10-15

Family

ID=63833896

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20211099TT HRP20211099T1 (hr) 2018-08-01 2021-07-09 Postupak za pripreme gabapentina

Country Status (7)

Country Link
US (1) US10399926B1 (hr)
EP (1) EP3604272B1 (hr)
DK (1) DK3604272T5 (hr)
ES (1) ES2880403T3 (hr)
HR (1) HRP20211099T1 (hr)
PL (1) PL3604272T3 (hr)
PT (1) PT3604272T (hr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2960441A (en) 1957-09-17 1960-11-15 Warner Lambert Pharmaceutical Therapeutic compositions of salts of 3, 3-pentamethylene-4-hydroxybutyric acid
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
IL144063A0 (en) 2001-06-28 2002-04-21 Bromine Compounds Ltd Process for the preparation of 1,1-cyclohexanediacetic acid
ITMI20041271A1 (it) 2004-06-24 2004-09-24 Zambon Spa Processo di preparazione di gabapentina
US8431739B2 (en) 2010-06-14 2013-04-30 Divi's Laboratories, Ltd. Process for the preparation of gabapentin
CN105061239A (zh) 2015-08-18 2015-11-18 太仓运通生物化工有限公司 一种加巴喷丁的合成方法

Also Published As

Publication number Publication date
DK3604272T3 (da) 2021-07-12
ES2880403T3 (es) 2021-11-24
PL3604272T3 (pl) 2021-10-25
EP3604272A1 (en) 2020-02-05
DK3604272T5 (da) 2021-08-02
US10399926B1 (en) 2019-09-03
EP3604272B1 (en) 2021-04-14
PT3604272T (pt) 2021-06-30

Similar Documents

Publication Publication Date Title
ES2660773T3 (es) Procedimiento para la preparación de una sal cristalina trialcalino-metálica de L-MGDA
HRP20210507T1 (hr) Supstituirani 5-fluoro-1h-pirazolopiridini u kristalnom obliku
WO2019211463A1 (en) Novel compounds
EP3692020A1 (en) Novel compounds
WO2019092172A1 (en) Novel sulfonamide carboxamide compounds
WO2019034697A1 (en) NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
WO2019034696A1 (en) NOVEL CARBOXAMIDE SULFONAMIDE COMPOUNDS
MX2013012798A (es) Compuestos heterociclicos fusionados como moduladores del canal de sodio.
EP4013761A1 (en) Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors
ZA200505600B (en) Piperidine derivatives as CCR5 antagonists
PE20121355A1 (es) Compuestos de ester de acido benzoico polimericos de sililo, usos y composiciones de los mismos
EA201391522A1 (ru) Способ получения соединений для применения в качестве ингибиторов sglt2
AR072447A1 (es) Proceso para preparar 2- alcoximetilen-4,4-difluoro-3-oxobutiratos de alquilo
DE102007018151A1 (de) Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
HRP20211099T1 (hr) Postupak za pripreme gabapentina
NZ751256A (en) Method for producing the crystalline form of modification a of calcobutrol
HRP20200580T1 (hr) Novi spojevi
AR086931A1 (es) Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de receptores de crth
HRP20140124T1 (hr) Postupak tionacije i tionacijsko sredstvo
MX2011012443A (es) Metodo para producir microcapsulas.
AR084579A1 (es) Moduladores del receptor de glucagon
EP4316598A3 (en) Pharmaceutical composition containing poorly-soluble basic medicine
PE20100140A1 (es) Nuevo acido l-glutamico marcado con [f-18] y derivados de l-glutamina marcada con [f18] (ii), su uso y procedimientos para su preparacion
MD4484C1 (ro) Forma cristalină VIII a agomelatinei, procedeu de preparare, utilizarea acesteia şi compoziţie farmaceutică care o conţine
WO2010107993A3 (en) Process for preparing (r)-7v-benzyl-2- (benyloxycarbonylamino)-s-methoxypropionamide